IP Library Granted Patent US 6,858,421
Granted Patent B2
US 6,858,421 · App. 10/266,388 · Granted Feb 22, 2005

Cytosolic phospholipase A2-beta enzymes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,421
App. No.
10/266,388
Granted
Feb 22, 2005
Kind
B2
Abstract

The invention provides a novel calcium-independent cytosolic phospholipase A 2 -Beta enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic acid cascade.

Claims (32)

1. A method for identifying an inhibitor of phospholipase activity, said method comprising:

a) contacting a phospholipid with a candidate inhibitor compound and a phospholipase enzyme peptide, wherein the phospholipase enzyme peptide comprises an amino acid sequence selected from:

i) the amino acid sequence of SEQ ID NO: 2;

ii) a fragment of the amino acid sequence of SEQ ID NO: 2 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate;

iii) the amino acid sequence of SEQ ID NO: 4; and

iv) a fragment of the amino acid sequence of SEQ ID NO: 4 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate; and

b) determining whether the phospholipase enzyme peptide cleaves the phospholipid and releases fatty acid, thereby identifying an inhibitor of phospholipase activity.

2. The method of claim 1 , wherein the phospholipase enzyme peptide comprises the amino acid sequence of SEQ ID NO: 2.

3. The method of claim 1 , wherein the phospholipase enzyme peptide comprises a fragment of the amino acid sequence of SEQ ID NO: 2 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate.

4. The method of claim 1 , wherein the phospholipase enzyme peptide comprises the amino acid sequence of SEQ ID NO: 4.

5. The method of claim 1 , wherein the phospholipase enzyme peptide comprises a fragment of the amino acid sequence of SEQ ID NO: 4 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate.

6. A method for identifying an inhibitor of phospholipase activity, said method comprising:

a) contacting a phospholipid with a candidate inhibitor compound and a phospholipase enzyme peptide, wherein the phospholipase enzyme peptide comprises an amino acid sequence selected from:

i) the amino acid sequence of SEQ ID NO: 2;

ii) a fragment of the amino acid sequence of SEQ ID NO: 2 having activity in a mixed micelle assay wish 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate;

iii) the amino acid sequence of SEQ ID NO: 4; and

iv) a fragment of the amino acid sequence of SEQ ID NO: 4 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate; and

b) determining whether the phospholipase enzyme peptide activity is inhibited by the candidate inhibitor compound,

thereby identifying an inhibitor of phospholipase activity.

7. The method of claim 6 , wherein the phospholipase enzyme peptide comprises the amino acid sequence of SEQ ID NO: 2.

8. The method of claim 6 , wherein the phospholipase enzyme peptide comprises a fragment of the amino acid sequence of SEQ ID NO: 2 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate.

9. The method of claim 6 , wherein the phospholipase enzyme peptide comprises the amino acid sequence of SEQ ID NO: 4.

10. The method of claim 6 , wherein the phospholipase enzyme peptide comprises a fragment of the amino acid sequence of SEQ ID NO: 4 having activity in a mixed micelle assay with 1-palmitoyl-2[ 14 C]-arachidonyl-phosphatidylcholine as a substrate.

11. A method for identifying an inhibitor of phospholipase activity, said method comprising:

a) contacting a phospholipid with a candidate inhibitor compound and a phospholipase enzyme peptide, wherein the phospholipase enzyme peptide comprises an amino acid sequence encoded by a polynucleotide that hybridizes to the nucleic acid sequence set forth in SEQ ID NO: 1 under stringent conditions of 4×SSC at 65 degrees C.; and

b) determining whether the phospholipase enzyme peptide activity is inhibited by the candidate inhibitor,

thereby identifying an inhibitor of phospholipase activity.

12. A method for identifying an inhibitor of phospholipase activity, said method comprising:

a) contacting a phospholipid with a candidate inhibitor compound and a phospholipase enzyme peptide, wherein the phospholipase enzyme peptide comprises an amino acid sequence encoded by a polynucleotide that hybridizes to the nucleic acid sequence set forth in SEQ ID NO: 3 under stringent conditions of 4×SSC at 65 degrees C.; and

b) determining whether the phospholipase enzyme peptide activity is inhibited by the candidate inhibitor,

thereby identifying an inhibitor of phospholipase activity.

13. The method of any one of claims 1 - 12 , further comprising forming a composition comprising the inhibitor and a pharmaceutically acceptable carrier.